What standard should Dermani Medspa's Business Associate use to determine when a Breach is treated as discovered?

According to the 2025 Dermani Medspa Franchise Disclosure Document, the Business Associate must adhere to the standard outlined in 45 C.F.R. § 164.410(a) to determine when a breach of unsecured Protected Health Information (PHI) is considered discovered. This regulation likely provides specific criteria and guidelines for assessing when a breach should be officially recognized.

This means that Dermani Medspa franchisees, as Business Associates, need to be familiar with and understand the requirements detailed in 45 C.F.R. § 164.410(a). This understanding is crucial for ensuring compliance with HIPAA regulations and for properly responding to any potential breaches of unsecured PHI. Failure to adhere to this standard could result in legal and financial repercussions for the franchisee.

In the event of a breach, the Business Associate is obligated to report it to the Covered Entity (likely Dermani Medspa itself) without unreasonable delay, and no later than five days after the discovery. The notification must comply with 45 C.F.R. § 164.410 and include all information required for individual notifications under 45 C.F.R. § 164.404(c). Furthermore, the Business Associate must cooperate with the Covered Entity to notify affected individuals and the media, if required by 45 C.F.R. § 164.406.